Omada Health to Participate in J.P. Morgan Healthcare Conference
Rhea-AI Summary
Omada Health (NASDAQ: OMDA) announced senior management will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.
The company will present on Wednesday, Jan. 14, 2026 at 9:00 a.m. PST. A live webcast and subsequent replay will be available at https://investors.omadahealth.com/news-events/events.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, OMDA gained 6.83%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Key health information peers like SDGR, TDOC, GDRX, OMCL, and PHR show positive moves (up to 2.67%), while OMDA sits near its 52-week low with only a modest 0.55% gain, and no peers appear in the momentum scanner.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 20 | Conference participation | Neutral | -4.9% | Evercore Healthcare Conference participation and webcast details. |
| Nov 06 | Earnings results | Positive | -6.1% | Strong Q3 growth, margin gains, first positive adjusted EBITDA, raised guidance. |
| Nov 06 | Product expansion | Positive | -6.1% | Nationwide GLP‑1 prescribing capability and strong member growth metrics. |
| Nov 04 | Clinical data update | Positive | -1.2% | ObesityWeek real‑world GLP‑1 outcomes and persistence data. |
| Oct 27 | Leadership change | Positive | +2.1% | Appointment of a new Chief Medical Officer to lead clinical strategy. |
Recent history shows multiple positive fundamental and clinical updates followed by negative 24-hour price reactions, suggesting a pattern of selling into good news.
This announcement about participating in the J.P. Morgan Healthcare Conference follows a series of growth and clinical milestones. In Q3 2025, OMDA reported revenue of $68.0M and raised full-year guidance, yet shares fell about 6%. Positive GLP‑1 data at ObesityWeek 2025 and a GLP‑1 prescribing expansion also saw negative reactions. A leadership addition on Oct 27 drew a modest gain. Another conference participation notice on Nov 20 coincided with a nearly 5% drop, framing today’s conference news within a pattern of cautious trading around updates.
Market Pulse Summary
The stock moved +6.8% in the session following this news. A strong positive reaction aligns with OMDA’s growing profile, given repeated appearances at major industry conferences and recent GLP‑1 program expansion. However, past news on earnings and clinical data often saw selling pressure despite positive fundamentals. Insider Form 4 filings over the last quarter showed net selling by key executives, which could temper enthusiasm if the move extended far above the $14.50 area and toward prior levels.
AI-generated analysis. Not financial advice.
SAN FRANCISCO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 44th Annual J.P. Morgan Healthcare Conference, taking place in San Francisco, including a presentation on Wednesday, Jan. 14, at 9 a.m. PST. The webcast will be available online at https://investors.omadahealth.com/news-events/events. A replay will also be available at the same link following the event.
About Omada Health
Omada Health (Nasdaq: OMDA) is a virtual between-visit healthcare provider that addresses cardiometabolic conditions like diabetes, hypertension, prediabetes, and obesity, as well as musculoskeletal issues. Through specialized care tracks, Omada also supports members taking GLP-1s and other anti-obesity medications. Our unique approach of Compassionate Intelligence combines human-led care teams, connected devices, and AI-powered technology to deliver personalized care at scale.
With more than a decade of experience and data, and 30 peer-reviewed publications that showcase its clinical and economic results, Omada has served over one million members since launch across more than 2,000 customers, including pharmacy benefit managers, health plans, health systems, and employers ranging in size from small businesses to Fortune 500s. Its evidence-based approach and commitment to bending the curve of chronic disease has earned the company multiple healthcare accreditations and recognition in the industry.
As a trusted partner in the healthcare ecosystem, Omada delivers measurable results that help to improve health outcomes and to manage healthcare costs. For more information, visit omadahealth.com.
Contacts
Allan Kells
IR@omadahealth.com
Rose Ramseth
press@omadahealth.com
FAQ
When will Omada Health (OMDA) present at the J.P. Morgan Healthcare Conference?
How can investors watch Omada Health (OMDA) presentation on Jan. 14, 2026?
What is the event where Omada Health (OMDA) will participate in January 2026?
Who from Omada Health will attend the J.P. Morgan conference?
Will there be a replay of Omada Health's (OMDA) J.P. Morgan presentation?
